
Brainsway Ltd. BWAY
$ 19.04
0.11%
Annual report 2024
added 12-27-2025
Brainsway Ltd. Operating Expenses 2011-2026 | BWAY
Annual Operating Expenses Brainsway Ltd.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 29.2 M | 28.4 M | 32.7 M | 28.1 M | 21.8 M | 26.4 M | 17.9 M | 15.2 M | 11.2 M | 9.84 M | 10 M | 5.26 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 32.7 M | 5.26 M | 19.7 M |
Operating Expenses of other stocks in the Diagnostics research industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Akumin
AKU
|
778 M | - | -17.87 % | $ 25.9 M | ||
|
Centogene N.V.
CNTG
|
58 M | - | -6.23 % | $ 30.6 M | ||
|
Accelerate Diagnostics
AXDX
|
77.2 M | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
21.6 M | - | -13.05 % | $ 7.29 M | ||
|
Burning Rock Biotech Limited
BNR
|
726 M | $ 20.25 | -3.5 % | $ 217 M | ||
|
Co-Diagnostics
CODX
|
45.3 M | $ 5.35 | 5.87 % | $ 157 M | ||
|
Castle Biosciences
CSTL
|
59.5 M | $ 38.31 | -1.52 % | $ 1.06 B | ||
|
Chembio Diagnostics
CEMI
|
28.5 M | - | 0.22 % | $ 16.8 M | ||
|
Danaher Corporation
DHR
|
6.71 B | $ 230.53 | 0.7 % | $ 169 B | ||
|
DexCom
DXCM
|
1.69 B | $ 66.36 | -0.02 % | $ 25.6 B | ||
|
BioNano Genomics
BNGO
|
41.3 M | $ 1.56 | 1.96 % | $ 1.98 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
59.4 M | - | - | $ 562 M | ||
|
Enzo Biochem
ENZ
|
47.4 M | - | -8.98 % | $ 14.8 K | ||
|
DermTech
DMTK
|
104 M | - | -11.32 % | $ 2.94 M | ||
|
DarioHealth Corp.
DRIO
|
62.2 M | $ 11.2 | -1.58 % | $ 318 M | ||
|
Exact Sciences Corporation
EXAS
|
2.98 B | $ 101.8 | 0.24 % | $ 18.9 B | ||
|
IQVIA Holdings
IQV
|
2.94 B | $ 225.76 | 0.16 % | $ 40.9 B | ||
|
Fulgent Genetics
FLGT
|
181 M | $ 25.77 | -1.9 % | $ 779 M | ||
|
Global Cord Blood Corporation
CO
|
451 M | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
134 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
5.91 M | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
983 M | - | 0.12 % | $ 80.1 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
585 M | - | - | $ 10.7 B | ||
|
Heska Corporation
HSKA
|
131 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
24.1 M | - | -20.0 % | $ 1.06 M | ||
|
CareDx, Inc
CDNA
|
484 M | $ 19.08 | 1.27 % | $ 1.03 B | ||
|
Celcuity
CELC
|
113 M | $ 99.7 | -0.05 % | $ 3.93 B | ||
|
Anixa Biosciences
ANIX
|
9.98 M | $ 3.11 | -0.32 % | $ 99.2 K | ||
|
Myriad Genetics
MYGN
|
709 M | $ 6.23 | 1.22 % | $ 564 M | ||
|
Guardant Health
GH
|
226 M | $ 101.54 | -0.59 % | $ 12.5 B | ||
|
ENDRA Life Sciences
NDRA
|
10.8 M | $ 4.21 | -7.06 % | $ 2.26 M | ||
|
NeoGenomics
NEO
|
382 M | $ 11.7 | -0.51 % | $ 1.48 B | ||
|
National Research Corporation
NRC
|
38.5 M | $ 18.42 | -1.86 % | $ 452 M | ||
|
Aspira Women's Health
AWH
|
37.1 M | - | -6.19 % | $ 10.5 M | ||
|
OPKO Health
OPK
|
217 M | $ 1.32 | 4.37 % | $ 916 M | ||
|
Koninklijke Philips N.V.
PHG
|
7.12 B | $ 27.16 | 0.3 % | $ 20 B | ||
|
Precipio
PRPO
|
13.6 M | $ 23.35 | 1.61 % | $ 30.3 M | ||
|
Personalis
PSNL
|
44.5 M | $ 7.95 | -0.13 % | $ 471 M | ||
|
Motus GI Holdings
MOTS
|
18.6 M | - | -34.28 % | $ 263 K | ||
|
Illumina
ILMN
|
3.69 B | $ 132.66 | 1.14 % | $ 21.1 B | ||
|
Charles River Laboratories International
CRL
|
607 M | $ 200.04 | 0.28 % | $ 10.3 B | ||
|
Quest Diagnostics Incorporated
DGX
|
1.46 B | $ 172.92 | -0.35 % | $ 19.2 B | ||
|
Biodesix
BDSX
|
106 M | $ 6.72 | -1.25 % | $ 871 M | ||
|
Laboratory Corporation of America Holdings
LH
|
1.87 B | $ 251.95 | 0.43 % | $ 21.1 B | ||
|
ICON Public Limited Company
ICLR
|
408 M | $ 188.4 | 3.39 % | $ 15.5 B | ||
|
IDEXX Laboratories
IDXX
|
1.25 B | $ 664.7 | -1.75 % | $ 54.8 B | ||
|
Lantheus Holdings
LNTH
|
123 M | $ 67.47 | 1.38 % | $ 4.67 B | ||
|
Mettler-Toledo International
MTD
|
1.01 B | $ 1 406.1 | 0.85 % | $ 29.8 B | ||
|
Agilent Technologies
A
|
1.99 B | $ 137.01 | 0.69 % | $ 41.7 B |